Hormone Refractory Prostate Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer
Condition: Prostate CancerInterventions: Drug: Cabazitaxel (XRP6258); Drug: prednisoloneSponsor: SanofiActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2011 Category: Research Source Type: clinical trials
Blood for Immune Response to Provenge® in HRPC
Condition: Prostate CancerIntervention: Sponsor: Mary Crowley Medical Research CenterWithdrawn - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2011 Category: Research Source Type: clinical trials
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Condition: Prostate Cancer MetastaticIntervention: Drug: CABAZITAXELSponsor: SanofiActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2010 Category: Research Source Type: clinical trials
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Condition: Prostate Cancer MetastaticIntervention: Drug: CABAZITAXELSponsor: SanofiCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2010 Category: Research Source Type: clinical trials
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
Conditions: Metastatic Cancer; Prostate CancerInterventions: Drug: docetaxel; Genetic: RNA analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: circulating tumor cell analysis; Other: laboratory biomarker analysisSponsor: ICORG- All Ireland Cooperative Oncology Research GroupRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2010 Category: Research Source Type: clinical trials